Cmed Clinical Services stelt nieuwe operationeel directeur aan
HORSHAM, England–(BUSINESS WIRE)– Cmed Clinical Services, een op technologie gericht eClinical-bedrijf voor uitbesteed onderzoek, heeft vandaag bekendgemaakt dat het Graham Belgrave heeft benoemd tot zijn operationeel directeur.
Belgrave is uit hoofde van deze functie verantwoordelijk voor de dagelijkse klinische activiteiten van het bedrijf. Hij werkt in het Verenigd Koninkrijk en verrijkt Cmed met veel ervaring in mondiale klinische ontwikkeling, strategie, klinische activiteiten, outsourcing en projectmanagement.
“We zijn blij dat we Graham Belgrave binnen onze organisatie mogen verwelkomen”, zei David Connelly, ceo van Cmed. “Graham heeft een geweldig werkverleden van vele jaren in de farmacie en zijn brede kennis van klinische ontwikkeling vult in combinatie met zijn sterke leiderschapskwaliteiten ons bestaande bestuur aan. Hij is van grote waarde voor de doorgaande groei van Cmed.”
Cmed Clinical Services Appoints New Chief Operations Officer
HORSHAM, England–(BUSINESS WIRE)– Cmed Clinical Services, an eClinical technology-led CRO, announced today the appointment of Graham Belgrave as Chief Operations Officer.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160114005858/en/
Graham Belgrave, Chief Operations Officer, Cmed Clinical Services (Photo: Business Wire)
In this role, Belgrave will be responsible for the company’s day-to-day clinical operating activities. He will be based in the UK and brings to Cmed a wealth of experience in global Clinical Development, Strategy, Clinical Operations, Outsourcing and Project Management.
“We are excited to welcome Graham Belgrave to our organization” said Dr. David Connelly, Cmed’s CEO. “Graham has a great track record over many years in the pharmaceutical industry and his breadth of clinical development experience across many therapy areas in Phases I-IV combined with his strong leadership skills will complement and strengthen our existing senior management team. He will be a valuable asset to Cmed as we continue to drive growth”.
Belgrave joins Cmed from German Headquartered pharmaceutical company Grunenthal GmbH, where he was SVP Global Head Clinical Development, Science and Operations. Prior this, he has worked at companies such as Vernalis, Pfizer and GSK, and has worked in consultancy and interim management positions, including in Oncology at Roche. From a career spanning over 30 years, he has built a strong clinical operations and drug development background as well as successfully leading outsourcing and vendor management organizations. He is a Fellow of the Royal Society of Medicine (Oncology and clinical research sections) and he is an experienced chairperson, speaker and committee member of various industry congresses and symposia.
– ends –
About Cmed
Cmed provides innovative e-clinical data capture and management technologies with CRO capabilities allowing sponsors to make faster, better decisions. Cmed’s technology uniquely improves workflow processes including eSource, remote monitoring, and risk based monitoring between sites, investigators, monitors, data managers, biostatisticians, and sponsors allowing easier access to the data anytime, for any trial, anywhere. For more information visit www.cmedresearch.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160114005858/en/
Contacts
Cmed
Anna Forster
aforster@cmedresearch.com
+44(0) 1403-755050